Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
The First Affiliated Hospital of Guangzhou Medical University
Fundación GECP
Second Affiliated Hospital of Guangzhou Medical University
Oslo University Hospital
University of Chicago
H. Lee Moffitt Cancer Center and Research Institute
Duke University
Massachusetts General Hospital
Bristol-Myers Squibb